DeviceTalks Weekly cover art

DeviceTalks Weekly

DeviceTalks Weekly

By: DeviceTalks Podcast Network
Listen for free

About this listen

Hosted by Tom Salemi, DeviceTalks Weekly is the foundational podcast for the entire DeviceTalks Podcast Network. The series delivers weekly news, insights, and commentary from MedTech industry leaders, keeping the medical device industry in the know and inspiring medical technology professionals to build better MedTech devices and companies.© 2025 Hygiene & Healthy Living Politics & Government
Episodes
  • Ep 70 - How Abbott and Cordis are working to change the interventional vascular business
    Aug 13 2021
    Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline. This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed. Subscribe to this podcast on all major podcast applications!
    Show More Show Less
    1 hr and 4 mins
  • Ep 69 - Why Koya CEO Doraiswamy is tackling lymphedema; Follow Todd Brinton’s unlikely path to Edwards
    Aug 6 2021
    This week’s episode focuses on the entrepreneurs. We open up with an interview with Andy Doraiswamy, founder and CEO of Koya Medical, a company he founded to help find a therapy for his ailing father. Then we revisit with Dr. Todd Brinton, chief scientific officer and corporate vice president at Edwards. This interview initially ran in May 2020 but we’re playing it again to amplify the unusual path that entrepreneurs take to find success.
    Show More Show Less
    1 hr and 4 mins
  • Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul
    Jul 30 2021
    This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.
    Show More Show Less
    1 hr and 20 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.